Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. [1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR ...
Polymyalgia rheumatica (PMR) is an elderly onset syndrome characterised by aching and stiffness in the shoulders and the pelvic girdle associated to increased levels of acute phase reactants and rapid ...
Our results support the hypothesis that a low initial dose of prednisone is sufficient to control PMR in the majority of patients. They also suggest that 0.20 mg per kg weight could be the ...
Objective: To develop a composite score for measurement of disease activity in polymyalgia rheumatica (PMR) and assess its internal and external validity. Methods: A PMR activity score (AS) was ...
Objective To assess whether the polymyalgia rheumatica (PMR)-like syndrome reported as an immune related adverse event (irAE) from checkpoint inhibitor therapy is consistent with the 2012 European ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
Background Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. Objectives To evaluate the efficacy and safety of first-line tocilizumab in PMR.
Looking forward, IMARC Group expects the 7MM to reach US$ 373.7 Million by 2034, exhibiting a growth rate (CAGR) of 4.63% during 2024-2034. Polymyalgia Rheumatica Market: The 7 major polymyalgia ...
After hours: February 20 at 6:45:26 PM EST Loading Chart for NA ...
Laurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 28,119.32 Crore) operating in Pharmaceuticals sector. Laurus Labs Ltd. key Products/Revenue Segments ...
Lambda Labs, a Nvidia partner, has lost its chief operating officer to a little-known company building hardware for the AI industry. Mitesh Agrawal told Business Insider he stepped into a new role ...